GAMCO Investors’s Aimmune Therapeutics AIMT Stock Holding History

GAMCO Investors’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-214,157	Closed	-$7.38M	–	924
2020 Q3	$7.38M	Buy	+214,157	New	+$4.56M	0.08%	271

GAMCO Investors's AIMT Position: Q4 2020 in Review

GAMCO Investors sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 214,157 shares — an estimated $7.38M sold.

GAMCO Investors first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $7.38M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

GAMCO Investors reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
GAMCO Investors sold 214,157 Aimmune Therapeutics shares in Q4 2020, an estimated $7.38M.
GAMCO Investors first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
GAMCO Investors's Aimmune Therapeutics position peaked at $7.38M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on GAMCO Investors's 13F filing for Q4 2020, filed 5 Feb 2021.